Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Franck Alexandre Silva0
Stephen Joseph Shuttleworth0
Date of Patent
May 30, 2017
Patent Application Number
14382196
Date Filed
March 8, 2013
Patent Citations Received
Patent Primary Examiner
Patent abstract
A compound of formula I: or a pharmaceutically acceptable salt thereof, wherein: R1, R2, R3, R and R6 are each independently (LQ)mY; R4 is H, halogen, optionally substituted aryl or optionally substituted alkyl; and; each X is independently CR7 or N. The compounds are PI3K inhibitors and therefore have potential utility in therapy.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
